NCT05882773Recruiting
Asian Myeloproliferative Neoplasm (MPN) Registry
Asian Myeloproliferative Neoplasm (MPN) Registry - An Asian Myeloid Working Group (AMWG) Project.
Source: ClinicalTrials.gov · Last updated 31 May 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This is a multinational, multicenter, prospective and retrospective, observational, cohort study of patients with myeloproliferative neoplasm.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 1000 (estimated)
- First submitted
- 21 May 2023
- Start date
- May 2023
- Primary completion date
- May 2026
- Lead sponsor
- The University of Hong Kong
- Diseases
- Myeloproliferative neoplasms
- NCT number
- NCT05882773
What you commit to
- Study type: Observational
- Planned participants: 1000
- From May 2023 to the primary completion date, May 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- 1\. Subject was diagnosed with myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, or chronic myeloid leukaemia BCR-ABL1 positive, under the 2017 WHO classification
Other
- A subject will not be eligible if he/she meets any of the following criteria:
Who the study is looking for
- Age ≥ 18 years old at the time of diagnosis of MPN.
- Subject was diagnosed with one of the following disorders according to the 2017 WHO classification (for patients diagnosed before 2017, the bone marrow reports will be re-evaluated according to the 2017 WHO classification):
- Polycythaemia vera
- Essential thrombocythemia
- Primary myelofibrosis, pre-fibrotic/early stage
- Primary myelofibrosis, overt fibrotic stage
- Post-polycythaemia vera myelofibrosis
- Post-essential thrombocythaemia myelofibrosis
- MPN-unclassifiable
- All subjects need to provide informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Department of Medicine, Queen Mary Hospital Coordinator of this site? Confirm its status | Hong Kong | Hong Kong | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.